Read the latest positive news, breakthroughs, and inspiring stories about drug affordability, curated daily by BrightWire.
A Michigan Supreme Court ruling just gave state investigators the green light to examine whether a major drug maker unfairly raised insulin prices. The decision could mean real answers for families who've struggled to afford life-saving medication.
Americans with diabetes just got major financial relief. A federal settlement with CVS Caremark will slash inflated insulin prices and could save patients up to $8.5 billion over the next ten years.
New research shows that cutting doses of top cancer drugs like Keytruda could save $30 billion worldwide while working just as effectively. The finding could expand treatment access by 50 to 60% for patients who desperately need it.
CVS Caremark has agreed to settle federal charges that it inflated insulin prices, promising changes that could make the lifesaving diabetes medication more affordable. The move follows similar action by another major pharmacy manager, signaling real progress on drug pricing.